TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Uscom Limited ( (AU:UCM) ) has shared an update.
Uscom Limited, a leader in medical technology, has announced its FY2025 results and outlined drivers for FY2026. The company has achieved significant milestones, including global clinical adoption and sales in 52 countries, supported by over 1,200 peer-reviewed publications. Uscom’s strategic partnership with Foxconn for manufacturing and global distribution is expected to enhance its market position, focusing on high-margin products and expanding its digital and wireless technology offerings.
The most recent analyst rating on (AU:UCM) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Uscom Limited stock, see the AU:UCM Stock Forecast page.
More about Uscom Limited
Uscom Limited is a world-leading medical technology company with a global presence in cities such as Sydney, Singapore, Beijing, Budapest, London, and Delaware. The company specializes in cardiovascular and pulmonary devices, expanding its product portfolio with digital technology and wireless connectivity. Uscom is known for its flagship science and technology in the cardiovascular and pulmonary sectors, addressing diseases responsible for over 75% of all mortality. The company has a manufacturing partnership with Foxconn to support growth and has made over 75 IP submissions to protect its technology.
Average Trading Volume: 127,000
Technical Sentiment Signal: Sell
Current Market Cap: A$3.12M
Learn more about UCM stock on TipRanks’ Stock Analysis page.